We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
State Street
STT
$50.9B
| $4.73M | 0.02% |
64,473
+17,719
| +38% | +$1.24M |
|
|
VAR
327
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.7M | 0.02% |
68,922
-142
| -0.2% | -$9.46K |
|
328
Chubb
CB
$140B
| $4.67M | 0.02% |
45,163
-632
| -1% | -$62.1K |
|
|
GTLS
329
DELISTED
Chart Industries
GTLS
| $4.62M | 0.02% |
+48,290
| New | +$5.08M |
|
330
Las Vegas Sands
LVS
$30.5B
| $4.58M | 0.01% |
58,127
-190
| -0.3% | -$13.7K |
|
331
Boeing
BA
$165B
| $4.58M | 0.01% |
33,522
+232
| +0.7% | +$30.2K |
|
332
Tapestry
TPR
$28.8B
| $4.48M | 0.01% |
79,872
-12,433
| -13% | -$672K |
|
|
PPBI
333
DELISTED
Pacific Premier Bancorp
PPBI
| $4.47M | 0.01% |
284,214
+17,125
| +6% | +$245K |
|
334
Target
TGT
$62.1B
| $4.47M | 0.01% |
70,589
-4,248
| -6% | -$272K |
|
335
Deere & Co
DE
$170B
| $4.4M | 0.01% |
48,130
+5,505
| +13% | +$466K |
|
|
TUC
336
DELISTED
MAC-GRAY CORP
TUC
| $4.39M | 0.01% |
206,610
+410
| +0.2% | +$8.27K |
|
337
Kimberly-Clark
KMB
$36.4B
| $4.33M | 0.01% |
43,244
-680
| -2% | -$67.9K |
|
338
Stoneridge
SRI
$209M
| $4.27M | 0.01% |
334,971
| – | – |
|
339
AB InBev
BUD
$158B
| $4.25M | 0.01% |
40,111
+34,431
| +606% | +$3.52M |
|
340
Prudential Financial
PRU
$41.7B
| $4.17M | 0.01% |
45,157
| – | – |
|
341
Thermo Fisher Scientific
TMO
$211B
| $4.16M | 0.01% |
37,343
+6,680
| +22% | +$664K |
|
342
iShares S&P India Nifty 50 Index Fund
INDY
$545M
| $4.12M | 0.01% |
175,421
+69,521
| +66% | +$1.58M |
|
343
Amazon
AMZN
$2.5T
| $4.03M | 0.01% |
201,880
+10,980
| +6% | +$197K |
|
344
Cedar Fair
FUN
$1.78B
| $4.01M | 0.01% |
80,933
-700
| -0.9% | -$32.5K |
|
345
Diageo
DEO
$46.2B
| $3.98M | 0.01% |
30,063
+1,568
| +6% | +$200K |
|
|
CELG
346
DELISTED
Celgene Corp
CELG
| $3.94M | 0.01% |
46,634
+3,944
| +9% | +$312K |
|
|
NUAN
347
DELISTED
Nuance Communications, Inc.
NUAN
| $3.94M | 0.01% |
299,018
-25,872
| -8% | -$356K |
|
|
MRSH
348
Marsh
MRSH
$86.3B
| $3.85M | 0.01% |
79,547
+2,909
| +4% | +$135K |
|
349
Travelers Companies
TRV
$80.8B
| $3.83M | 0.01% |
42,305
+1,371
| +3% | +$120K |
|
|
ORBC
350
DELISTED
ORBCOMM, Inc.
ORBC
| $3.82M | 0.01% |
602,008
+8,520
| +1% | +$51.3K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.